EGF Theramed Health Corp.
EVAHF · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.05 | -0.00 | 0.07 | -0.01 |
| FCF Yield | -2.37% | 0.00% | 0.31% | -0.01% |
| EV / EBITDA | -59.30 | -1.33 | -640.94 | -23.71 |
| Quality | ||||
| ROIC | 0.73% | 0.29% | 5.01% | -12.99% |
| Gross Margin | 0.00% | 0.00% | 0.00% | 0.00% |
| Cash Conversion Ratio | 0.49 | -0.06 | 0.71 | -4.65 |
| Growth | ||||
| Revenue 3-Year CAGR | -100.00% | -100.00% | -100.00% | -100.00% |
| Free Cash Flow Growth | 0.00% | 0.00% | 2,833.33% | -179.58% |
| Safety | ||||
| Net Debt / EBITDA | -35.76 | -0.73 | -347.82 | -10.95 |
| Interest Coverage | -1.80 | -0.42 | -5.21 | 13.62 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | 0.00 | 0.00 | 0.00 | 0.00 |